Spread mainly by fruit bats, Nipah virus is fatal in up to 85% of cases. Symptoms include fever, headaches, pain, vomiting ...

KØBENHAVN, DK / ACCESS Newswire / June 10, 2025 / FluoGuide A/S (STO:FLUO) - Copenhagen, Denmark - FluoGuide A/S ("FluoGuide" or the "Company"), a clinical-stage biotech company focused on precision ...

KØBENHAVN, DK / ACCESS Newswire / June 10, 2025 / FluoGuide A/S (STO:FLUO) - Copenhagen, Denmark - FluoGuide A/S ("FluoGuide" or the "Company"), a clinical-stage biotech company focused on precision c ...

Merck reports positive results from the first two phase 3 CORALreef trials of enlicitide decanoate to treat adults with hyperlipidemia: Rahway, New Jersey Tuesday, June 10, 2025, ...

Rahway: Merck, known as MSD outside of the United States and Canada, has announced positive topline results from the first ...

The woman started experiencing intense anxiety and heart palpitations. A young person might have shrugged off such symptoms, ...

Meanwhile, Sanofi has pointed to Beyfortus’ 75% reduction in the incidence of MALRI versus Enflosia’s figure of 60%. The ...

Spironolactone does not reduce the rate of cardiovascular death or heart failure in patients undergoing maintenance dialysis.

Known as Enflonsia, the drug will compete for market share with Sanofi and AstraZeneca’s in-demand Beyfortus, which quickly ...

James Flaherty, MD, an interventional cardiologist and associate professor of medicine at Northwestern Memorial Hospital in Chicago, serves as medical director of the hospital’s coronary care unit. He ...

As stakeholders debate fair market value in clinical trial budgeting, a new task force works to align sponsors, CROs, and ...

Results from the Phase III CORALreef HeFH and CORALreef AddOn studies demonstrated tatistically significant and clinically ...